Providing market intelligence for more than 35 years

In The News

Where IoT and 2G Intersect

In early 2015, IoT research from Parks Associates predicted rapid growth in the smart home in 2015, as 37 percent of U.S. broadband households intended to buy one or more smart devices this year. The current positioning for consumer IoT products creates an expectation with consumers that IoT products like the Nest Learning Thermostat or Philips Hue should easily interoperate with other IoT devices in the home.

Given the fact that 20 percent of homes have professionally monitored security systems, there will be a high level of overlap between your current customers and this segment of smart home IoT early adopters. The opportunity for security dealers is to be savvy enough to tap into the IoT trend by making the security panel appear simply as one additional smart, connected IoT device in the home that they happen to already own.

From the article "Where IoT and 2G Intersect" by Shawn Welsh.

Previously In The News

Samsung Leads in 4K TV Sales, Report Shows

Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...